𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Phenotypic mixing of vesicular stomatitis virus and D-type oncornavirus

✍ Scribed by A. D. Altstein; V. M. Zhdanov; T. N. Omelchenko; S. G. Dzagurov; G. G. Miller; J. Zavada


Publisher
John Wiley and Sons
Year
1976
Tongue
French
Weight
358 KB
Volume
17
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

After mixed infection of cells with vesicular stomatitis virus (VSV, thermolabile mutant tl 17) and oncornavirus type D, phenotypically mixed virions are formed containing the VSV genome and oncornavirus and VSV envelope. The virions are thermostable and have serologic characteristics of both viruses.


πŸ“œ SIMILAR VOLUMES


Down-regulation of type I interferon rec
✍ Kai-xin Zhang; Yoshiyuki Matsui; Boris A. Hadaschik; Cleo Lee; William Jia; John πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 French βš– 589 KB

## Abstract The intrinsic oncolytic specificity of vesicular stomatitis virus (VSV) is currently being exploited to develop alternative therapeutic strategies for bladder cancer and other cancers. Previously we reported that oncolytic VSV is a potent agent for intravesical treatment of high risk bl

Poliovirus and vesicular stomatitis viru
✍ Gerald Goldstein; Louis E. Guskey πŸ“‚ Article πŸ“… 1984 πŸ› John Wiley and Sons 🌐 English βš– 541 KB

The effects of 6-diazo-5-oxo-L-norleucine (DON), 2-deoxy-D-glucose (DOG), and tunicamycin (TM) on the replication of poliovirus (PV) and vesicular stomatitis virus (VSV) were examined. During a 48-hr replication period, TM, DON, and DOG inhibit VSV plaque formation in HEp-2 cells by 99.9%, 99.8%, an

Pseudotypes of vesicular stomatitis viru
✍ Attila BΓ‘csi; Peter Ebbesen; Judit SzabΓ³; ZoltΓ‘n Beck; IstvΓ‘n AndirkΓ³; Eszter Cs πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 308 KB

## Abstract Intrauterine infection of the fetus is clearly an important mode of vertical transmission of human immunodeficiency virus type 1 (HIV‐1). The syncytiotrophoblast layer of the human placenta must be traversed by HIV‐1 in order to reach underlying cells and fetal capillaries. Although HIV